| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Jan 02, 2024 | Sale | $20.00 | 2,004 | 40,080 | 51,831 | Jan 04, 2024, 05:23 PM | |
| RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Dec 18, 2023 | Option Exercise | $17.74 | 2,749 | 48,767 | 56,643 | Dec 20, 2023, 04:10 PM | |
| RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Dec 19, 2023 | Option Exercise | $18.09 | 2,808 | 50,797 | 53,835 | Dec 20, 2023, 04:10 PM | |
| RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Jun 07, 2023 | Sale | $20.04 | 4,049 | 81,142 | 59,392 | Jun 09, 2023, 04:05 PM | |
| RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Dec 16, 2022 | Sale | $30.75 | 2,453 | 75,430 | 11,953 | Dec 16, 2022, 09:44 PM | |
| RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Dec 16, 2021 | Sale | $39.83 | 485 | 19,315 | 7,771 | Dec 20, 2021, 04:22 PM | |
| RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Dec 17, 2021 | Sale | $40.36 | 621 | 25,061 | 7,502 | Dec 20, 2021, 04:22 PM | |
| RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | Chief Financial Officer | Sep 09, 2020 | Buy | $21.57 | 5,000 | 107,849 | 5,000 | Sep 09, 2020, 04:53 PM | |
| UBX | Unity Biotechnology, Inc. | Goeltz II Robert C. | Chief Financial Officer | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 161,027 | Jun 24, 2020, 05:03 PM | |
| UBX | Unity Biotechnology, Inc. | Goeltz II Robert C. | Chief Financial Officer | Feb 24, 2020 | Option Exercise | $3.43 | 10,000 | 34,300 | 134,404 | Feb 26, 2020, 05:48 PM | |
| UBX | Unity Biotechnology, Inc. | Goeltz II Robert C. | Chief Financial Officer | Oct 10, 2018 | Option Exercise | $3.43 | 5,000 | 17,150 | 101,348 | Oct 12, 2018, 05:36 PM | |
| CTMX | CytomX Therapeutics, Inc. | Goeltz II Robert C. | Chief Financial Officer | May 12, 2017 | Option Exercise | $5.54 | 19,967 | 110,700 | 32,756 | May 16, 2017, 04:57 PM | |
| CTMX | CytomX Therapeutics, Inc. | Goeltz II Robert C. | Chief Financial Officer | Apr 10, 2017 | Option Exercise | $4.47 | 3,000 | 13,418 | 12,789 | Apr 11, 2017, 12:51 PM | |
| CTMX | CytomX Therapeutics, Inc. | Goeltz II Robert C. | Chief Financial Officer | Mar 20, 2017 | Sale | $12.14 | 43,034 | 522,581 | 31,306 | Mar 21, 2017, 06:05 PM | |
| CTMX | CytomX Therapeutics, Inc. | Goeltz II Robert C. | Chief Financial Officer | Mar 09, 2017 | Option Exercise | $4.47 | 2,500 | 11,182 | 9,789 | Mar 09, 2017, 07:22 PM | |
| CTMX | CytomX Therapeutics, Inc. | Goeltz II Robert C. | Chief Financial Officer | Nov 30, 2016 | Option Exercise | $9.10 | 1,289 | 11,723 | 7,289 | Dec 01, 2016, 07:01 PM | |
| CTMX | CytomX Therapeutics, Inc. | Goeltz II Robert C. | Chief Financial Officer | Sep 29, 2016 | Option Exercise | $4.47 | 4,000 | 17,891 | 6,000 | Oct 03, 2016, 02:32 PM | |
| CTMX | CytomX Therapeutics, Inc. | Goeltz II Robert C. | Chief Financial Officer | May 12, 2016 | Option Exercise | $4.47 | 2,000 | 8,946 | 2,000 | May 13, 2016, 04:05 PM |
Menu